The demand from research organisations and biopharmaceutical businesses is the main factor driving the MALDI-TOF mass spectrometry market. In these applications, the use of this technique enables the rapid and precise detection and identification of proteins, peptides, and other compounds. Additionally, compared to other detection techniques, MALDI-TOF mass spectrometry offers improved sensitivity and specificity. This market is expanding as a result of the growing usage of MALDI-TOF mass spectrometry in environmental and food safety testing. Environmental pollutants and toxins that threaten food safety can be accurately and quickly analysed thanks to this technology.
The need for early detection and better patient outcomes has arisen as a result of the rising prevalence of diseases like cancer, cardiovascular diseases, and respiratory problems worldwide. To achieve this requirement, scientists are searching for strong instruments to more accurately test proteins at the molecular level. The accurate analysis of proteins and other substances provided by MALDI-TOF mass spectrometry makes it a crucial tool for the detection and management of numerous diseases.
Due to the growing use of mass spectrometry in biopharmaceutical research projects, the MALDI-TOF mass spectrometry market is anticipated to expand strongly throughout the projected period of 2021–2031. The benefits of this technology, such as its high sensitivity compared to conventional methods, low cost, and simplicity of use, are projected to propel market expansion. Additionally, it is widely utilised in diagnostic labs to locate and recognise biological molecules including proteins and peptides, which are anticipated to drive market expansion. Additionally, its capacity to identify several compounds in a single run with the aid of sophisticated algorithms is anticipated to propel the growth of this market.
Complex mixtures of chemicals can be analysed and characterised using the MALDI-TOF mass spectrometry technology. The molecules are disassembled by means of lasers into minute pieces, which a mass spectrometer may subsequently examine. Scientists are able to identify and quantify chemicals, proteins, and other compounds with the aid of the data obtained by MALDI-TOF analysis.
The market for MALDI-TOF mass spectrometry is projected to be worth USD 1.75 billion in 2021 and USD 2.87 billion in 2031, growing at a CAGR of 5.7% during the forecast period.
The MALDI-TOF Mass Spectrometry market is constrained by issues including high capital expenditure and consumables costs. Due to the current global economic crisis, businesses are probably going to spend less on lab equipment. Such devices' high manufacture and maintenance costs prevent them from being widely used in consumer markets or low-cost laboratories. In addition, the expansion of this sector is hampered by the lack of technical know-how and skilled employees to run this equipment. However, it is anticipated that these issues will be overcome in the upcoming years due to the growing knowledge of this technology and its uses. Several government programmes to support research, provide clinical applications, and boost the funding available for instrumental analysis may also contribute to the market's growth.
Shimadzu Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Bruker Corporation, PerkinElmer Inc., SCIEX (Danaher Corporation), and JEOL Ltd. are important market participants in the MALDI-TOF mass spectrometry market.
The Below 2000FWHM Type to Emerge as the Most Lucrative Segment
In 2020, the market's largest share belonged to the below 2000 FWHM segment because it allows for increased molecular structure data precision and has a variety of applications. Due to its higher sensitivity compared to spectrometers with lower resolution, the 2000 to 5000 FWHM category had the second-largest share in 2020. Additionally, because it can generate high-resolution images and deliver more accurate results, the Above 5000 FWHM category is anticipated to experience expansion at a higher rate during the projection period.
The Most Popular Application Segment is Biopharmaceuticals Companies
The market was dominated by biopharmaceutical businesses in 2020 as a result of the rising usage of mass spectrometry in drug development, particularly for proteomics investigations. In addition, the segment of research institutes is anticipated to expand significantly over the course of the forecast year as a result of an increase in partnerships between academics and industry. Clinical laboratories, governmental organisations, and contract research organisations (CROs) are included in the other sector; these entities are also anticipated to be key users of MALDI-TOF mass spectrometry over the forecast period.
North American region to render Adequate Financing Avenues
North America, South America, Asia Pacific, Europe, the Middle East, and Africa are the regional divisions of the MALDI-TOF mass spectrometry market. Due to elements such the existence of numerous biopharmaceutical firms, technological improvements, and the growing emphasis on proteomics research, North America dominated the market in 2020. Furthermore, the Asia Pacific region is anticipated to experience considerable growth over the course of the forecast period as a result of factors like the region's major companies increasing their R&D spending and the rising demand for personalised medication.
COVID-19 Impact and Market Status
The COVID-19 pandemic has altered the MALDI-TOF Mass Spectrometry market globally, resulting in lower demand across a number of industries. Due to the inability to meet agreed delivery deadlines, the pandemic has changed industrial capabilities and supply chains. However, a lot of businesses are quickly adjusting to the present environment. Examples include encouraging remote labour, automating production procedures, and implementing digital platforms. Additionally, a lot of businesses are now working on developing cutting-edge products that are anticipated to expand the chances in the MALDI-TOF Mass Spectrometry market throughout the course of the projection year.
Latest Innovations in the Global MALDI-TOF Mass Spectrometry Market: A Snapshot
• In 2019, the American molecular diagnostics firm Cepheid Inc. was purchased by Danaher Corporation. By enhancing its product line, the acquisition improved the company's position in the MALDI-TOF mass spectrometry market.
• A new MALDI-TOF mass spectrometry system with cutting-edge software and hardware was unveiled by Waters Corporation. It enhances the performance of peptide mapping and offers users a high degree of freedom for their study.
MALDI-TOF Mass Spectrometry Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2032||USD 2.87 billion|
|Growth Rate||CAGR of 5.7% during 2021-2031|
|Segment Covered||by Type, by Deployment, By Application, by Application, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and Africa|
|Key Players Profiled||Shimadzu Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Bruker Corporation, PerkinElmer Inc., SCIEX (Danaher Corporation), and JEOL Ltd.|
Key Segments of the MALDI-TOF Mass Spectrometry
• Below 2000FWHM
• Above 5000FWHM
By Application Overview, 2021-2031 (USD Billion)
• Biopharmaceuticals Companies
• Research Institutions
Regional Overview, 2021-2031 (USD Billion)
• Rest of Europe
• Rest of Asia Pacific
• Rest of South America
Middle East and Africa